GlassScriptPhysician profile
Sarah Jane Polow
NPI 1518924521
$5,524.61
in general payments reported to CMS, 2019-2025
46 companies · $656 in 2025
The $656 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $717 · 2020: $540 · 2021: $1,365 · 2022: $817 · 2023: $602 · 2024: $828 · 2025: $656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,086.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,086.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $564.94 | 2019-2025 | Repatha, Otezla, Repatha |
| Pfizer INC. | $514.59 | 2019-2025 | |
| Abbvie INC. | $478.83 | 2019-2025 | |
| Novo Nordisk INC | $477.68 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Sanofi-Aventis U.S. LLC | $398.92 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $332.02 | 2021-2025 | Xifaxan, Trulance |
| Astrazeneca Pharmaceuticals LP | $313.56 | 2019-2025 | Airsupra, Breztri |
| Glaxosmithkline, LLC. | $298.69 | 2019-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Astellas Pharma US INC | $175.42 | 2020-2024 | Veozah |
| Grt US Holding, INC. | $169.00 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $151.06 | 2022-2025 | |
| Lilly USA, LLC | $139.22 | 2019-2025 | Jardiance, Zepbound |
| Merck Sharp & Dohme LLC | $136.00 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $134.85 | 2019-2022 | |
| Tonix Medicines, INC. | $84.05 | 2025 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Polow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.